The United States has officially informed an additional 25 % tariff on Indian imports, which is scheduled to enter into force as of August 27 (9:31 am). But a closer look at the notification reveals major details: many major Indian exports, including iron, steel, aluminum, copper, cars and some electronics, exempt from these duties.
The supplement is buried for the products listed under specific HTSUS addresses, especially those related to basic minerals, vehicle parts and industrial derivatives. This gives Indian exporters some breathing room – at least at first.
But how long will these exemptions continue – especially for medicines, given what Donald Trump has just said?
On August 25, the US President issued a sharp warning: The prices of drugs in the United States will be reduced by 1400 % to 1500 %, and the tariffs on imported drugs may rise to 250 %. He said during a briefing, “Going to carry out a number on the costs of medicines in the United States,” which indicates an aggressive step to force companies to reduce prices and transport manufacturing.
The Trump administration has already set a final date on September 29 for the best Pharma-including Pfizer, J & J, GSK, Merck and Novartis-to expand the “most preferred” drugs to all Medicaid patients. Trump has warned against not compliance, which would lead to the use of “every tool in our arsenal”, including definitions.
In an interview with CNBC earlier this month, Trump launched a three -stage tariff plan:
- Start with the “small” import duty,
- Row to 150 % in 18 months,
- Maybe 250 % after that.
While pharmaceutical exports in India-which is an annual business of $ 25 billion-are not called directly in the latest exemptions, they are still exposed to future tariff waves, especially if Trump targets low-cost drug makers.
https://akm-img-a-in.tosshub.com/businesstoday/images/story/202508/68ad4c076ab6d-while-indias-pharmaceutical-exports–a-25-billion-plus-annual-business–are-not-directly-named-i-265409420-16×9.jpg
Source link